|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2101 Batch: A210126
Anti-mouse CD4 antibody(Clone:GK1.5) reacts with mouse CD4, which is a 55 kDa cell surface type I membrane glycoprotein. CD4 is a co-receptor of the T cell receptor (TCR) and assists the latter in communicating with antigen-presenting cells.
| Formulation | PBS buffer, pH 6.5 |
|---|---|
| Clone | GK1.5 |
| Immunogen | Mouse CTL clone V4 |
| Isotype | Rat IgG2b,κ |
| Application | In vivo CD4+ T cell depletion,FCM,WB |
| Source | CHO |
| Murine Pathogen Screening Panel | all targets tested yielded Negative Results: Theiler’s Murine Encephalomyelitis Virus, Ectromelia (Mousepox) Virus, Hantavirus, Polyomavirus, Sendai Virus, Mycoplasma pulmonis, Pneumonia Virus of Mice, K Virus, Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Norovirus, Mouse Minute Virus, Mouse Cytomegalovirus, Mouse Adenovirus, Lactate Dehydrogenase-Elevating Virus, Reovirus Panel, Lymphocytic Choriomeningitis Virus, Mouse Rotavirus. |
| Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
| Shipping | Shipped under low temperature conditions |
| Sterility | 0.2 μM filtered |
| Purity | 99% |
| Protein concentration | 7.45 mg/ml |
| Endotoxin Level | <1EU/mg |




| FLT3L combined with GM-CSF induced dendritic cells drive broad tumor-specific CD8+ T cell responses and remodel the tumor microenvironment to enhance anti-tumor efficacy [ Frontiers in Immunology, September 4, 2025, 16:1649891] | PubMed: 40977690 |
| Spatiotemporal Analysis of Mesenchymal Stem Cells Fate Determination by Inflammatory Niche Following Soft Tissue Injury at a Single‐Cell Level [ Advanced Science, September 23, 2024, 11(43):2310282] | PubMed: 39308190 |
| LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation [ Cell Discovery, October 29, 2025, 11(1):84] | PubMed: 41162356 |
| TREM2-Mediated Cholesterol Efflux in Macrophages Inhibits Anti-Tumor Immunity via Limitation of CD4+ T and NK Cells [ Advanced Science, October 20, 2025, 13(5):e06995] | PubMed: 41114464 |
| Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine [ Cell Reports Medicine, October 1, 2023, 4(10):101229] | PubMed: 37820722 |
| Silencing PCSK9 reshapes the spatiotemporal activation of STING for safe and effective cancer immunotherapy [ Nature Communications, November 25, 2025, 16(1):11622] | PubMed: 41290746 |
| Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells [ Nature Communications, November 24, 2023, 14(1):7709] | PubMed: 38001101 |
| DOCK2 protects against bacterial sepsis by constraining T helper 1 response [ Frontiers in Immunology, May 29, 2025, 16:1527934] | PubMed: 40510337 |
| Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction [ Signal Transduction and Targeted Therapy, May 16, 2025, 10(1):161] | PubMed: 40374605 |
| HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering [ Journal for ImmunoTherapy of Cancer, March 30, 2026, e014185] | PubMed: 41912269 |
人間や獣医の診断であるか治療的な使用のためにでない。